指南与共识头颈部肿瘤放疗

头颈部根治性放疗淋巴结靶区选择:2019年更新

Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update.
指南 / 共识 · Radiother Oncol · 2019-01-30

该2019年更新基于影像学、外科和病理学文献综述头颈部癌颈淋巴结转移规律,由全球头颈部放疗专家小组达成共识,针对口腔、口咽、下咽、喉、鼻咽、鼻窦、鼻腔及原发灶不明癌,依据UICC第8版淋巴结分期,更新并扩展了阴性颈和阳性颈高危与低危淋巴结靶区的选择建议。

要点

  • 基于影像学、外科和病理学文献综述初发侵犯与失败模式,专家小组达成共识。
  • 更新覆盖口腔、口咽、下咽、喉、鼻咽、鼻窦、鼻腔及原发灶不明癌的淋巴结靶区选择。
  • 靶区选择按UICC第8版淋巴结分期区分阴性颈与阳性颈的高危和低危淋巴结靶区。

核心结论

  • 头颈部癌采用IMRT/VMAT或其他高度适形技术(如质子治疗)时,淋巴结靶区选择需要严谨的方法。
  • 该更新版选择建议应有助于临床医生选择淋巴结靶区并促进一致性提高。

研究设计与样本

  • 基于影像学、外科和病理学文献,全面综述头颈部癌颈淋巴结转移的初发侵犯与失败模式。
  • 由全球头颈部放疗专家小组就阴性颈和阳性颈的高危与低危淋巴结靶区选择达成共识。
  • 在2000年专家小组提出的头颈部根治性放疗淋巴结靶区选择建议基础上进行更新,并扩展至先前未覆盖的原发部位。

主要发现

  • 报告了口腔、口咽、下咽、喉、鼻咽、鼻窦、鼻腔及原发灶不明癌的淋巴结靶区更新选择,按UICC第8版淋巴结分期区分。
  • 选择建议覆盖阴性颈和阳性颈的高危与低危淋巴结靶区。

关键数值与推荐

  • 淋巴结靶区选择按UICC第8版淋巴结分期进行。
  • 针对阴性颈和阳性颈分别选择高危和低危淋巴结靶区。
  • 靶区选择适用于IMRT/VMAT或其他高度适形技术(如质子治疗)。

临床怎么用

  • 该更新建议供临床医生在选择头颈部癌淋巴结靶区时参考,以促进一致性提高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: In 2000, a panel of experts published a proposal for the selection of lymph node target volumes for definitive head and neck radiation therapy (Radiother Oncol, 2000; 56: 135-150). Hereunder, this selection is updated and extended to also cover primary sites not previously covered. PATIENTS AND METHODS: The lymphatic spread of head and neck cancers into neck lymph nodes was comprehensively reviewed based on radiological, surgical and pathological literature regarding both initial involvement and patterns of failure. Then a panel of worldwide head and neck radiotherapy experts agreed on a consensus for the selection of both high- and low-risk lymph node target volumes for the node negative and the node positive neck. RESULTS: An updated selection of lymph node target volumes is reported for oral cavity, oropharynx, hypopharynx, larynx, nasopharynx, paranasal sinuses, nasal cavity and carcinoma of unknown primary as a function of the nodal staging (UICC 8th edition). CONCLUSIONS: The selection of lymph node target volumes for head and neck cancers treated with IMRT/VMAT or other highly conformal techniques (e.g. proton therapy) requires a rigorous approach. This updated proposal of selection should help clinicians for the selection of lymph nodes target volumes and contribute to increase consistency.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Biau J, Lapeyre M, Troussier I, et al. Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiother Oncol. 2019. PMID: 31005201. doi:10.1016/j.radonc.2019.01.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。